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CORRESPONDENCEOcular Defects as Surrogate End-Points in Trials Comparing
Carotid Endarterectomy and Stenting
The effect of carotid endarterectomy (CEA) and carotid ar-
tery stenting (CAS) on visual function has not been a speciﬁc
end-point of most trials comparing CAS and CEA. Ischaemic
lesions of the retina and optic nerve have been reported to
occur in 15e46% of carotid patients,1 while carotid artery
stenosis signiﬁcantly reduces blood ﬂow to the eye and
orbit, resulting in the ocular ischaemic syndrome.2e5
Both CAS and CEA have been reported to prevent further
episodes of amaurosis fugax, correct paresis of the pupil
muscle, decrease neovascularization of the optic nerve
head and iris, and improve blood ﬂow to the orbital ves-
sels.1e5 However, emboli generated during CAS and CEA
may also cause ischaemic lesions of the ophthalmic artery,
leading to transient or permanent blindness.6,7 Ophthalmic
artery colour Doppler ﬂow imaging, ﬂuorescein angiog-
raphy, and retinal photography have been used to detect
new emboli generated during the carotid revascularization
procedures.6
CAS is associated with a higher incidence of cerebral
microemboli compared with CEA.8e10 These microemboli
are major risk factors for postprocedural cerebral deﬁcits.8e
10 Although most of these microembolic events are not
associated with deterioration in cognitive performance and
functions, or may only be associated with a transient
dysfunction, their long-term effects are uncertain.11 It has
been suggested that subclinical infarcts on magnetic reso-
nance imaging (MRI) are a risk factor for cognitive impair-
ment.12 Furthermore, such microemboli may contribute to
cognitive decline, vascular dementia, and Alzheimer’s dis-
ease,13,14 and may be associated with a higher (greater than
threefold) risk of future stroke.15 Therefore, long-term
follow-up with neurocognitive testing and repeated MRI
imaging may be essential to provide better insight into the
nature of these lesions.9,10
Although much attention has been given to the effects of
CAS and CEA on brain circulation, the effects of CAS versus
CEA on visual function are unknown. Improvement in blood
ﬂow following CEA/CAS can improve chronic ischaemia of
the orbital vessels but, on the other hand, it may turn out
that microemboli generated during CAS and/or CEA
adversely affect visual function. Current or future trials
comparing CAS and CEA may, therefore, provide a unique
opportunity to investigate and report on this subject.
The Asymptomatic Carotid Surgery Trial-2 (ACST-2) is
currently the largest trial to compare CASwith CEA in patients
with severe asymptomatic carotid stenosis.16 Thus, it may
represent a unique opportunity to investigate the effects of
both procedures on the eye circulation and the retina. Po-
tential differences between the two procedures may be used
as another surrogate end-point on which the merits of each
procedure could be judged. Finally, these results could pro-
vide additional useful data on the effects of carotid revas-
cularization procedures in asymptomatic patients.REFERENCES
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Progressive compression, plantar load and calf venous
pump
Mosti and Partsch1 exhaustively demonstrated that a pro-
gressive compression improves calf ejection fraction (cEF)
more than a classic regressive compression. These ﬁndingsFigure 1. A 63-year-old male. Baropodometric ﬁndings from the right foot in basic conditions (A), with multi-layer bandaging (B) and
CircAid Juxta-Fit applied without the compression anklet (C).were convincingly ascribed to the higher pressure obtained
at the calf “.where it is needed.”.
We are currently evaluating changes in ankle range-of-
motion (aROM) and plantar load related to different
compression devices. Our preliminary results suggest an
additional possible explanation.In fact, we observed that the higher the compression on
the foot and ankle, the greater the reduction of the aROM
and variations of both static and dynamic baropodometric
ﬁndings (Fig. 1A,B). In turn, in an experimental model of
progressive compression (CircAid Juxta-Fit applied without
the underlying elastic anklet, with a pressure of about
50 mmHg at the calf with no compression of the foot and
ankle), the aROM and baropodometry did not modify. Dis-
tribution of plantar load even improved in some cases
(Fig. 1C).
The mean age of the patients in whom Mosti and Partsch
calculated cEF after a standardizedwalking testwas 53.7 12.1
years, and 75% of legs were assigned to C-classes C3eC5. It is
well known that ageing and severity of venous insufﬁciency per
se reduce aROM, and that limited ankle ﬂexibility and plantar
abnormalities reduce the efﬁcacy of the calf pump.
Accordingly, it could be speculated that, besides the
positive effects of higher compression of the calf, the
greater cEF obtained with progressive stockings also could
be because of the lower “compression proﬁle” of the foot
and ankle, resulting in a more physiologic ﬂexibility of the
plantar and tibio-tarsal joints.
In turn, the higher compression exerted by regressive
stockings on the foot and ankle could possibly further
reduce their ﬂexibility, so inﬂuencing gait dynamics and
activation of pumping muscular chains. This would be
especially true for older subjects and those with more se-
vere venous insufﬁciency.REFERENCE
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